Bavarian Nordic shares pop over 13% on earnings beat, bumper mpox vaccine order
Highlights of the article: 1. Danish biotech company Bavarian Nordic saw a 13% increase in its shares following stronger-than-expected earnings and a significant vaccine order from an unnamed European country during an ongoing mpox outbreak. 2. The company reported second-quarter revenues of 1.43 billion Danish krone and an operating profit of 420 million krone, exceeding […]
